Archive | Vicente LLP

Colorado Natural Medicine Program Draft Rules Released And Public Hearing Scheduled

By Barine Majewska
Apr 24, 2024

DORA recently presented additional draft rules for Colorado’s regulated natural medicine market to the Natural Medicine Advisory Board, focused on facilitator conduct and relationships, administrative sessions, informed consent, record keeping and advertising. DORA will host a virtual public hearing on the new rules on April 26 and the Natural Medicine Division of the Department of Revenue will host a stakeholder meeting on Healing Center requirements on May 1. These are important opportunities to make your voices heard! Read this article for details on the rules and instructions for joining the meetings.

Psychedelics Lawyer Joshua Kappel Will Discuss Microdosing 101 At NeueHouse Educational Event in NYC

Apr 22, 2024

Curious about microdosing psychedelics? Join Vicente LLP psychedelics attorney Joshua Kappel on April 25 at NeueHouse in New York City for a night filled with education, resources, and legality around microdosing. RSVP now!

Vicente LLP Psychedelics & Emerging Therapies Update: April 2024

Apr 12, 2024

Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.

Colorado Natural Medicine Advisory Bulletin #10.1: Legislative Update

By Vicente LLP, Psychedelic Alpha
Apr 9, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #10.1 features Vicente LLP's review of SB 24-198, the first legislative update since the passing of SB23-290 in 2023, which implemented the NMHA.

Colorado Natural Medicine Advisory Bulletin #10: March 2024

By Vicente LLP, Psychedelic Alpha
Apr 6, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #10 focuses on updates from the recent meeting of the Natural Medicine Advisory Board, where draft rules for Facilitator licensing and training were discussed.

Vicente Psychedelics Attorneys Headed to San Francisco for Chacruna Psychedelic Culture Conference

Apr 5, 2024

Vicente LLP founding partner Joshua Kappel and counsel Barine Majewska will be at the upcoming “Cultivating Roots for Cultural Change: the Bay Area’s Annual Spring Conference on Plant Medicines & Psychedelic Science.” Hosted by Chacruna, the event will take place on April 27 and 28, 2024, at the historical Brava Theater Center in San Francisco, California.

Vicente Attorneys Will Sponsor and Attend Bridging the Worlds Psychedelics Conference

Apr 5, 2024

On April 18, 2024, Vicente LLP attorneys Joshua Kappel and Barine Majewska will attend the “Bridging the Worlds: The Confluence of Indigenous Wisdom and Psychedelic Science” conference at the University of Colorado Anschutz Medical Campus in Aurora, CO. Vicente is a sponsor of the event, which will explore the future of psychedelic research in the context of its historical and cultural significance.

[Webinar] From Maryland Lottery to Cannabis Business License: Priorities, Strategies & Solutions

Apr 5, 2024

Watch this informative webinar with members of Vicente’s Maryland and Corporate teams and Cannabis Capital Advisors’ Christopher Stefan. Panelists will guide attendees with essential next steps to successfully navigate Maryland’s cannabis industry, including insights into the application review process, compliance requirements, and financing options for raising capital to build an operational cannabis business in Maryland.

Vicente LLP is Headed to Florida for the 2024 Benzinga Cannabis Capital Conference

Apr 2, 2024

Join us at the 2024 Benzinga Cannabis Capital Conference on April 16-17 in Hollywood, Florida! You can find us on stage discussing cannabis banking and business diversification and connect with our attorneys and our director of compliance during the conference.

[Webinar] Cannabis IP Strategies: A Forward-Looking Discussion with Patent & Trademark Specialists

Mar 28, 2024

Watch this pre-recorded session to learn about the future of intellectual property for cannabis and hemp products with rescheduling on the horizon. This webinar will feature a discussion with VLLP IP specialists regarding patent, IP and trademark protection, cannabis research, and what may change with potential federal marijuana rescheduling.

Colorado Natural Medicine Advisory Bulletin #9: February/March 2024

By Vicente LLP, Psychedelic Alpha
Mar 20, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #9 focuses on updates from the recent meeting of the Natural Medicine Advisory Board and listening sessions held by the Department of Revenue and the Department of Regulatory Agencies Stakeholder Engagement Meeting.

Cannabis Economist Andrew Livingston Will Discuss Research Challenges in Cannabis and Psychedelic Markets at The Emerald Conference

Mar 15, 2024

On April 2, The Emerald Conference will feature a talk by Vicente LLP director of economics and research Andrew Livingston on how variations between the cannabis and psychedelic markets may influence research design, data collection, and overall program evaluation. Register to attend and learn more!

Colorado's Draft Natural Medicine Rules: Full Breakdown & Commentary

By Vicente LLP, Psychedelic Alpha
Mar 5, 2024

Vicente LLP provides a full breakdown of the first set of draft rules regarding Colorado's regulated psychedelics program. The thirty-nine pages of draft rules cover facilitator licensing and training programs, representing months of work by the Natural Medicine Advisory Board and state regulators.

New Year, New Rules: Updated Oregon Psilocybin Services Regulations Now in Effect

By Yolanda Clarke
Feb 27, 2024

Oregon's psilocybin program has updated its regulations, clarifying existing rules and addressing new areas like data reporting and facilitator training. Key changes involve distinguishing between mandatory anonymized data collection and optional personal information from clients, requiring state licensing or specific exemptions for facilitator training programs, and emphasizing nondirective facilitation with support resources instead of advice. Read this Insights post to learn more about the recent rule changes for psilocybin in Oregon.

Colorado's Draft Natural Medicine Rules: A High-Level Overview

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 27, 2024

Vicente LLP shares a high-level overview of the first draft rules for Colorado's regulated natural medicine market. These draft rules focus on facilitator qualifications, education requirements, and training programs.

Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: February 2024

Feb 20, 2024

Federal and international law and policy insights, news and events from Vicente LLP

Colorado Natural Medicine Advisory Bulletin #8.1: Recommendation Round-Up

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 15, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #8.1 gives context to the 123 recommendations which will form the basis of the regulated nature medicine program approved by Colorado voters in November 2022.

Colorado Natural Medicine Advisory Bulletin #8: January 2024

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Feb 14, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #8 focuses on updates on the NMAB's initial set of recommendations for the state’s regulated natural medicine program

Colorado Natural Medicine Advisory Bulletin #7: December 2023

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Jan 18, 2024

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #7 focuses on updates from the recent subcommittee meetings.

Join us! Psychedelics Investor Forum in Costa Rica Featuring Shawn Hauser and Sally Kent Peebles

Dec 19, 2023

On Wednesday, January 10, 2024, Vicente LLP partners Shawn Hauser and Sally Kent Peebles will be participating in a psychedelics investor forum in Nosara, Costa Rica! This is a one-of-a-kind event dedicated to exploring the latest national legislation and its pivotal impact on mental health. Register now!

Vicente LLP Psychedelics & Emerging Therapies Update: December 2023

Dec 19, 2023

Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.

Colorado Natural Medicine Advisory Bulletin #6: November 2023

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Dec 13, 2023

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #6 focuses on updates from the recent subcommittee meetings and the full meeting of the Natural Medicine Advisory Board.

A Potential Breakthrough for Psychedelic Treatments: Ninth Circuit Court Ruling on Psilocybin Rescheduling

By Jason Adelstone
Dec 7, 2023

On October 27, 2023, the Ninth Circuit Court of Appeals, in Aggarwal v. DEA, held that the U.S. Drug Enforcement Agency (DEA) must reconsider its denial of a petition to transfer psilocybin, the active ingredient in “magic mushrooms” from Schedule I to Schedule II. Read this Insights post for more information about the Ninth Circuit Court’s order to reschedule psilocybin.

SXSW 2024 Will Feature Psychedelics Attorneys Joshua Kappel and Shawn Hauser

Nov 29, 2023

Vicente LLP psychedelics attorneys Joshua Kappel and Shawn Hauser were selected to speak on panels focused on functional alcohol substitutes and psilocybin medicine during the Psychedelics Track at SXSW in March 2024.

Colorado Natural Medicine Advisory Bulletin #5: October 2023

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Nov 14, 2023

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #5 focuses on updates from the October subcommittee meetings and the full meeting of the Natural Medicine Advisory Board.

Inc. 5000 Conference & Gala Features Psychedelics Discussion with Joshua Kappel

Oct 26, 2023

Vicente LLP founding partner Joshua Kappel will discuss the new age of psychedelics and how natural medicines can help entrepreneurs at the prestigious Inc. 5000 Conference & Gala on November 1.

Vicente LLP Psychedelics & Emerging Therapies Update: October 2023

Oct 26, 2023

Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.

Colorado Psychedelics Implementation Update: DOR Natural Medicine Division Listening Sessions - Part 1

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Oct 24, 2023

As part of the pre-rulemaking process, the Colorado Department of Revenue's Natural Medicine Division began holding public “Listening Sessions” with the goal of gathering information from the public at large. The October sessions consisted of five, one-hour, online meetings focused on specific topics announced in advance. Read this article for a summary of the first five sessions.

Colorado Natural Medicine Advisory Bulletin #4: September 2023

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Oct 17, 2023

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #4 focuses on updates from the September subcommittee meetings and the full meeting of the Natural Medicine Advisory Board.

Oregon and Colorado Psychedelics Panel at Wonderland Features Shawn Hauser

Oct 17, 2023

Watch Vicente LLP partner Shawn Hauser present on Thursday, November 9 during Wonderland Miami! Shawn is slated to discuss the state of the emerging psychedelics industries in Oregon and Colorado. Register now!

[Webinar] Special Briefing on Cannabis Federal Scheduling Reform

Oct 4, 2023

Watch this special briefing where Vicente LLP leaders share insights on the impacts of the HHS recommendation to reschedule cannabis and outline the road ahead.

Psychedelic Missouri Freedom Conference Will Feature Joshua Kappel Discussing Decriminalizing and Commercializing Psychedelics

Oct 2, 2023

Joshua Kappel is a featured speaker at the Psychedelic Missouri Freedom Conference, which will be held on October 21. His panel discussion, “Decriminalizing & Commercializing Psychedelics,” will also feature Andreas Met of Satya Therapeutics and Saint Louis University adjunct professor Charlotte Jones.

[Webinar] Preparing for New York Cannabis Business Licensing

Sep 14, 2023

New York's adult-use cannabis licensing is set to open in the fall, and members of Vicente LLP’s New York team and a special guest from Dutchie provide answers to the “who, what, where, when and how” questions on the minds of prospective Empire State cannabis licensees during this webinar replay.

Vicente LLP's Psychedelics & Emerging Therapies Update: September 2023

Sep 11, 2023

Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.

Vicente LLP's Psychedelics & Emerging Therapies Update: January 2024

Sep 11, 2023

Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.

Colorado Natural Medicine Advisory Bulletin #3: August 2023

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Sep 7, 2023

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #3 focuses on updates from the August subcommittee meetings and the full meeting of the Natural Medicine Advisory Board. In addition, the Department of Revenue will hold NMHA listening sessions throughout September.

PsyCon Will Feature Vicente LLP Attorneys Joshua Kappel and Yolanda Clarke Discussing Colorado Natural Medicine Health Act Updates and Licensing

Aug 29, 2023

What are the latest updates on Natural Medicines in Colorado? What are the opportunities for entering Colorado’s psychedelic ecosystem? Attend Joshua Kappel and Yolanda Clarke’s sessions at PsyCon Denver on September 29 to find out the answers to these questions. Register now!

Colorado Natural Medicine Advisory Bulletin #2: July 2023

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 14, 2023

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #2 focuses on updates from the July subcommittee meetings and full meeting of the Natural Medicine Advisory Board.

Colorado Natural Medicine Advisory Bulletin #1: Background

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 14, 2023

Colorado Natural Medicine Advisory Bulletins provide updates on the implementation of Colorado's legal psychedelics program, the Natural Medicine Health Act. Bulletin #1 focuses on the Natural Medicine Advisory Board: What is the board, how does the board work, what subcommittees exist, what have they done so far, and what's next?

Colorado Natural Medicine Health Act Tracker Produced by Vicente LLP and Psychedelic Alpha

By Joshua Kappel, Jeff Fitzgerald, Psychedelic Alpha
Aug 11, 2023

Vicente LLP is collaborating with Psychedelic Alpha to produce the Colorado Natural Medicine Health Act Tracker, which is dedicated to being a clearinghouse for the implementation of Colorado’s Natural Medicine Health Act, with a focus on the work of the Natural Medicine Advisory Board and its subcommittees.

City of West Hollywood Community Educational Forum on Psilocybin Features Psychedelics Attorney Joshua Kappel

Jul 12, 2023

Learn about and support psychedelic policy by attending a community educational forum on psilocybin, featuring Vicente LLP founding partner Joshua Kappel, at the West Hollywood City Council Chambers on July 25, 2023. The educational forum will explore the full spectrum of psilocybin-related topics, including a discussion of past and current legislation aimed at decriminalizing psilocybin mushrooms and other hallucinogenic substances.

[Webinar] Opportunities in the Functional Mushroom Industry

Jul 12, 2023

Mushrooms are having a moment! Watch this session to learn about current and future business opportunities in the growing world of adaptogenic and functional mushrooms.

Vicente LLP's Psychedelics & Emerging Therapies Update: July 2023

Jul 7, 2023

Psychedelics and emerging therapies-related legislation, regulatory updates, events and other news from Vicente LLP.

Vicente LLP Receives Top Ranking in Cannabis Law from Chambers and Partners for the Fifth Year in a Row

Jun 12, 2023

Vicente LLP is honored to announce that the firm was recognized by Chambers and Partners as a top cannabis law practice in the U.S., and five of the firm's attorneys were individually ranked among the nation's top cannabis lawyers. Vicente has received a Nationwide Band 1 ranking from Chambers in all five years since the Cannabis Law section was added in 2019.

Join Vicente LLP at Psychedelic Science 2023 in Denver

Jun 7, 2023

The largest psychedelic gathering in history is coming to Denver June 19-23 and Vicente LLP is ecstatic to sponsor the conference and welcome the global psychedelic community to our hometown. Let’s connect at the conference and the many networking events that week!

The Six Main Functional Mushroom Types: Opportunities and Ongoing Research

By Charles Alovisetti, Sahar Ayinehsazian
Jun 5, 2023

While waiting for the emergence of state-regulated psilocybin markets or federal legalization, entrepreneurs interested in mushrooms have other options to pursue. Read this article to learn more about opportunities in functional mushrooms.

Legal Guide to Decriminalized Natural Medicine in Colorado

May 29, 2023

Colorado is the first state to decriminalize natural psychedelics for personal and communal use. This guide contains information on personal use, civil protections, and Colorado's regulated natural medicine access program. Natural psychedelics remain illegal under federal law. Please be conscientious and know the laws.

The Ultimate Guide to SB23-290, Colorado’s Natural Medicine Regulation and Legalization Bill

By Joshua Kappel, Juliana Todeschi, George Winfrey
May 24, 2023

Another key step in bringing natural psychedelic medicine to Colorado was completed this week. Governor Polis signed SB23-290, the Natural Medicine Health Act’s implementation bill. This bill is the most comprehensive piece of legislation ever passed by a state government related to a state-authorized natural psychedelic medicine program. It builds upon the values of the NMHA with a renewed focus on indigenous voices, safety, and regulatory efficiency. The measure goes into effect on July 1, 2023. Read our full analysis of the bill.

[Webinar] New York’s Revised Cannabis Regulations: What you need to know now to plan ahead and structure deals

May 17, 2023

Watch this Vicente LLP session where members of our New York team dive into the significant changes from the first draft of New York's cannabis regulations, how the new regulations will impact capital raises and M&A, and more!

Revised New York Adult-Use Cannabis Regulations: What You Need to Know

By Michelle Bodian, Elliot Choi, Brandon Kurtzman, Charles Alovisetti
May 11, 2023

On May 11, 2023, New York’s Cannabis Control Board voted to approve the revised adult-use cannabis regulations. The Office of Cannabis Management (OCM) has indicated adult-use cannabis applications will open up in the fall, meaning these revised regulations will function as our roadmap. This article outlines key changes in the revised regulations.

Buying a Ketamine Clinic: Why, How, and Risks to Understand

May 11, 2023

With ketamine being the only approved psychedelic drug for medical use, ketamine clinics offer a unique opportunity for investors and entrepreneurs looking to enter the expanding market of innovative mental health therapies. In this article, we will explore the reasons behind the growing demand for ketamine clinics and the unique regulatory considerations involved in transactions involving these businesses.

Yolanda Clarke Slated to Present 'Oregon Psilocybin Licensing 101' at Psycon Psychedelics Conference in Oregon

May 10, 2023

Vicente psychedelics and emerging therapies attorney Yolanda Clarke will share Oregon psilocybin licensing tips and insights at Psycon Oregon on May 19.

Key Aspects of New York's Cannabis Law and Draft Regulations

By Charles Alovisetti
May 8, 2023

New York's Cannabis Control Board meets this week and a revised set of draft regulations, reflecting comments from the initial period, is expected to be released before the meeting. Attend our webinar on May 17 for a deep dive into the revised regulations.

What You Need to Know About SB23-290, Colorado’s Natural Medicine Health Act Implementation Bill

By Genevieve Meehan and Sara Simons
May 3, 2023

Since its introduction on April 18, SB23-290, the implementation bill for the Natural Medicine Health Act (NMHA), made its way through the Colorado Legislature and now awaits the governor's signature. Although the bill started off with a couple of policy positions that were antithetical to the voter-initiated act, after a series of amendments and a lot of work by Colorado activists and lawyers, it seems clear SB23-290 builds off the intent of the NMHA to create a natural psychedelic ecosystem in Colorado based in equity and safety. Read this Vicente Insights post for key aspects of the bill.

Colorado Psychedelics Update: State House of Representatives Passes Natural Medicine Health Act Implementation Bill SB23-290 with Amendments

By Joshua Kappel
May 1, 2023

Since its introduction on April 18, SB23-290, the implementation bill for the Natural Medicine Health Act (NMHA), made its way through the Colorado House and has now passed with amendments that have generally brought this bill even closer to the original intent of Prop 122! Read this Vicente Insights post for the latest updates and next steps for the bill.

Colorado Psychedelics Update: Natural Medicine Health Act Implementation Bill SB23-290 Engrossed, Reengrossed, and Heading to the House

By Joshua Kappel, Juliana Todeschi
Apr 25, 2023

Since its introduction on April 18, SB23-290, the implementation bill for the Natural Medicine Health Act (NMHA), has gone through the Colorado Senate Finance and Appropriations Committees and several amendments have been made. The reengrossed version of the now 91-page bill heads to the state House with a new sponsor, Representative Judy Amabile. Read this Vicente Insights post for the latest updates and next steps for the bill.

Colorado Psychedelics Update: Natural Medicine Health Act Implementation Bill SB23-290 Amended During Public Hearing

By Joshua Kappel
Apr 21, 2023

SB23-290, the Natural Medicine Health Act (NMHA) implementation bill, had a hearing on April 20 in Colorado’s Senate Finance Committee. Amendments made during the hearing were a significant step in the right direction. Read this Vicente Insights post for our summary of the hearing and next steps for the bill.

Colorado Psychedelics Update: Natural Medicine Regulation and Legalization Bill Introduced in Colorado Legislature

By Joshua Kappel, Barine Majewska
Apr 19, 2023

SB23-290 was introduced in the Colorado Legislature to amend and implement Proposition 122, the Natural Medicine Health Act that was passed by Colorado voters in November. There will be a public hearing on this bill tomorrow, April 20. If passed, SB23-290 would completely replace the NMHA.

[Webinar] Equitable Access & Psychedelics

Apr 13, 2023

Making psychedelic-assisted therapy and training opportunities accessible to historically and systematically oppressed populations is essential to creating a more equitable healthcare model. But how can this be achieved? Watch this webinar for a discussion on equity and psychedelics with professionals from Alchemy Community Therapy Center.

Charles Alovisetti Presenting on Cannabis Law at Stockton University’s Annual Cannabis Convening

Apr 12, 2023

The Cannabis & Hemp Research Initiative at Stockton University is hosting its 3rd Annual Cannabis Curriculum Convening on April 27-28. Register for this virtual session to hear Vicente partner Charles Alovisetti discuss cannabis law.

Vicente LLP Partners Slated to Speak at 2023 NORML Cannabis Law and Business Seminar

Apr 10, 2023

Attend the NORML Denver Legal Seminar from June 7-9 to hear Vicente partners Charles Alovisetti, Sahar Ayinehsazian, Shawn Hauser, and Brian Vicente discuss the latest cannabis industry legal and business insights.

Trailblazers NYC 2023 Will Feature Jennifer Cabrera and Joshua Kappel

Apr 4, 2023

Vicente attorneys Joshua Kappel and Jennifer Cabrera are participating in Trailblazers’ highly anticipated second annual event in New York City on April 24-25!

Forming Psychedelic Companies: 10 Lessons from the Cannabis Industry

By Charles Alovisetti
Mar 22, 2023

A new industry is emerging in the United States, and entrepreneurs in the psychedelics space must make critical decisions at the onset of new ventures regarding how to set up and structure their new businesses. Luckily, we have access to another industry with a complex legal framework and a patchwork of different state laws: cannabis. And after forming hundreds of cannabis companies with clients over the past decade, Vicente LLP has lessons to be shared.

[Webinar] Restructuring Options in Cannabis: Out-of-Court Workouts

Mar 15, 2023

Cannabis businesses facing insolvency can't access federal bankruptcy courts, but they do have restructuring options. One of those options is an out-of-court workout between lenders and borrowers. Watch this Vicente LLP session to learn the practical issues around out-of-court workouts and cannabis companies.

[Webinar] New York Tri-state Cannabis Transactions: M&A, Financings, and New Licenses

Mar 9, 2023

Watch this session to learn how cannabis regulations impact M&A transactions and financings in Connecticut, New Jersey, and New York.

A Wake-up Call from Down Under: Australia's Therapeutic Goods Administration Reschedules Psilocybin and MDMA

By Shane Pennington
Mar 1, 2023

How TGA's rescheduling of psilocybin and MDMA shines a bright light on DEA delinquency

Vicente LLP and Grasslands Invite You to An Evening of Connection with Cannabis and Psychedelic Professionals During SXSW in Austin

Feb 23, 2023

Calling all cannabis and psychedelic industry professionals! RSVP to attend our private networking event and fundraiser during SXSW in Austin, co-hosted with Grasslands: A Journalism-Minded Agency.

[Webinar] Restructuring Options in Cannabis: Receiverships

Feb 16, 2023

Cannabis companies facing insolvency must use state receiverships or out-of-court workouts to restructure an insolvent business. But what does that mean, and what is the right choice for your business? Watch our live session on the practical issues around the receivership of cannabis companies.

Psychedelic Policy Reform in Michigan: A Brief History

By Krissy Atterholt
Feb 14, 2023

Michigan leads the Midwest in affording its communities local protection for psychedelic-based activities. This article gives a breakdown of notable moments in Michigan's psychedelic legislative history.

Explore the Legal Landscape for Microdosing Psychedelics with Josh Kappel on the Third Wave Podcast

Feb 9, 2023

What is microdosing and what does the path to legalizing responsible psychedelic use look like? Get the low-down from the Third Wave Podcast featuring Josh Kappel, Alli Schaper and Marie Mbouni, M.D.

Guidelines for the Personal Use of Psychedelics Under Colorado’s Natural Medicine Health Act of 2022

By Yolanda Clarke and Jaime Greenwood
Feb 3, 2023

Colorado's Natural Medicine Health Act provides a path for responsible access to psychedelic natural medicines. If you're interested in the personal use of natural medicines in Colorado, read this article to find out what is and is not permitted.

[Webinar] Psychedelic Opportunities in Oregon and Colorado

Jan 12, 2023

As states like Oregon and Colorado develop regulated pathways for people to get involved in the regulated psychedelics industry, possibilities—and questions—are increasing: What are the opportunities now, what’s next, and where? Get answers by watching this recorded session.

Proposition 122 Co-author Joshua Kappel Slated to Participate in Chacruna’s Community Forum on The Future of Colorado Psychedelics

Jan 10, 2023

Certain psychedelics were decriminalized in Colorado, now what? Join Chacruna’s Community Forum on January 18 for an in-depth discussion about the Natural Medicine Health Act.

Colorado Prop 122 Co-author Josh Kappel Joins Psychedelic Passage Podcast to Address Protections and Regulations Under the Natural Medicine Health Act

Jan 6, 2023

"Can I start selling mushrooms in Colorado now?" Joshua Kappel answers your questions about Proposition 122 on the Psychedelics Passage podcast. Listen here!

Financing Cannabis-Related Real Estate CLE Features Charles Alovisetti

Dec 27, 2022

In a CLE on January 12, 2023, Charles Alovisetti will offer advice on the legal and practical issues borrowers and lenders need to consider when documenting and funding a loan transaction secured by cannabis-related real estate

VS Participating in Upcoming Drug Conviction Record Sealing Clinic Hosted by The Color of Cannabis and NAACP Denver

Dec 23, 2022

On January 7, 2023, the VS team will provide legal services at a drug conviction record sealing clinic in Denver, Colorado.

Boston Magazine's 2022 'Top Lawyers' List Includes Eight Vicente Sederberg Attorneys

Nov 23, 2022

We're proud to announce that eight VS attorneys were included in Boston Magazine's 2022 'Top Lawyers' list! Congratulations to Brandon Kurtzman, Phil Silverman, Charles Alovisetti, David Ullian, Adam Fine, Jeremy Shaw, Meg Nash, and Michelle Bodian!

Oregon Psilocybin Services Releases New Proposed Rules and Public Comment Period

By Yolanda Clarke, Jamie Greenwood
Nov 16, 2022

In another exciting step towards implementing psilocybin services, the Oregon Psilocybin Services Section issued updated proposed rules under the Oregon Psilocybin Services Act this month, making significant changes to the previous iteration. Make your voices heard! The public comment period is open through November 21, 2022.

Colorado Votes on Psilocybin: Josh Kappel Joins Higher Practice Podcast to Discuss Prop. 122

Nov 4, 2022

Josh Kappel recently discussed everything related to Proposition 122: The Natural Medicine Health Act with Higher Practice Podcast. Listen now!

[Webinar] Cannabis & Psychedelics On the Ballot

Nov 1, 2022

The November 2022 ballot has those interested in cannabis and psychedelic policy reform on their toes. From supporting adult-use cannabis initiatives in Arkansas, Missouri, North Dakota, South Dakota, and Maryland, to potential psychedelic reform in Colorado, there is plenty of excitement!

Colorado Prop 122: A Transformative Measure Grounded in Equity and Healing

By Joshua Kappel and Tucker Wentz
Oct 11, 2022

Vicente Sederberg LLP is proud to stand with Natural Medicine Colorado and support Proposition 122. This measure not only provides safe access to natural psychedelic medicines, but does so in a way that is grounded in equity and conscious capitalism while also protecting legacy communities and existing medicine keepers.

Colorado Prop 122's Historic Environmental, Social & Governance (ESG) Requirements

By Marc Ross
Oct 11, 2022

Colorado Prop 122, The Natural Medicine Health Act, requires that licensed entities participating in the Natural Medicine Regulated Access Program must meet specific ESG criteria.

The Natural Medicine Health Act of 2022: A Measure to Access Psychedelic Medicine in Colorado

By Colleen Mitchell, Yolanda Clarke
Oct 10, 2022

Prop 122 would create a regulated system for adults aged 21 and older to access natural psychedelic medicine, such as psilocybin, in a supervised setting to treat various mental health conditions. It would also allow for the cultivation, possession, personal use, and gifting of psychedelic medicine for adults aged 21 and older. Read this for an overview of the proposition’s key components.

Charles Alovisetti and FL Gorman to Present ‘Cannabis and Insolvency: Debtor Creditor Rights & Remedies Under State and Federal Law’ on NYSBA Program

Oct 5, 2022

VS partners Charles Alovisetti and FL Gorman will discuss debtor-creditor rights pertaining to cannabis at NYSBA’s virtual CRE program on October 6

Raising Private Capital in the Cannabis Industry

By Charles Alovisetti, Elliot Y. Choi, and Sahar Ayinehsazian
Sep 29, 2022

Charles Alovisetti, Elliot Y. Choi, and Sahar Ayinehsazian write for the Bloomberg Law, reflecting on the challenges and journey of raising private capital in the cannabis industry

Oregon Health Authority Publishes Psilocybin Draft Rules: License Types, Ownership Requirements, and Location Specifics

By Sally Kent Peebles
Sep 9, 2022

Oregon Health Authority published the remaining draft rules to implement 'Measure 109' – the Oregon voter initiative passed in November 2020 which directed the OHA to license and regulate psilocybin products and the provision of psilocybin services. Read more about psilocybin licensing rules.

Join VS at the Emergence Psychedelic Education Festival in Denver!

Sep 7, 2022

Don’t miss the Emergence Psychedelic Education Festival on October 1, 2022. The event will feature psychedelic practitioners and advocates, including VS’s Barine Majewska.

Charles Alovisetti Talks Raising Capital in Upcoming Rootwurks Webinar 'The Search for Green Capital: The Funding Issues Cannabis Companies Face'

Aug 24, 2022

Register for this free Rootwurks webinar to hear from Charles Alovisetti about why raising capital can be so tricky for cannabis businesses.

Vicente Sederberg LLP Headed to Chicago for 2022 Benzinga Cannabis Capital Conference and Awards

Aug 24, 2022

Vicente Sederberg LLP will sponsor and speak at the Benzinga Cannabis Capital Conference AND—the firm is nominated for Best Cannabis Law Firm at the Benzinga Cannabis Awards.

Charles Alovisetti to speak on Cannabis & Regulations in New York City

Aug 17, 2022

Charles Alovisetti will be attending Empire State of Law: Hosted by LVLUP Legal in NYC for a panel titled, "Legalize It: Cannabis & Regulations" in NYC!

Psychedelic Law Summit Will Feature Josh Kappel on September 8th, 2022

Aug 10, 2022

Josh Kappel will be featured in a legalization and regulation panel at the Psychedelic Law Summit hosted by InsidePractice, "Legalization or Regulation: Pathways to Psychedelic Access"

Joshua Kappel Speaks on Microdosing, Psychedelics Policy and More for Into the Multiverse Podcast

Aug 8, 2022

VS founding partner Joshua Kappel was a featured guest on a panel hosted by Into The Multiverse Podcast to discuss the history and future of psychedelic microdosing.

Psychedelica Lex Interviews Joshua Kappel About Colorado’s Natural Medicine Health Act

Jul 22, 2022

Joshua Kappel was interviewed by Psychedelica Lex to discuss his advocacy for the Colorado Natural Medicine Health Act, a measure on the Fall ballot.

Natural Medicine Health Act — A Groundbreaking Ballot Measure for Access to Psychedelic Therapy

Jul 22, 2022

It's official! Coloradans will have the chance to vote on a historic ballot initiative this year to legalize possession of certain psychedelics, establish a therapeutic model for supervised psilocybin treatment and provide a pathway for record sealing for prior convictions.

Vicente Sederberg Receives Top Ranking from Chambers and Partners for Fourth Straight Year

Jul 6, 2022

VS is excited to announce that the prestigious international legal directory Chambers & Partners awarded VS with the 'Cannabis Law Firm of the Year' award once again, extended VS a Band 1 ranking for the fourth straight year, and recognized five VS attorneys as top cannabis lawyers.

[Webinar] Debt Financings in the Cannabis Industry

Jun 28, 2022

Watch this session to learn how debt financing can be a funding source for your cannabis business.

Understanding the Current Legal Status of Psychedelics in the United States

By Charlie Alovisetti, Genevieve Meehan, Josh Kappel
May 27, 2022

Do commercial opportunities for entrepreneurs exist in psychedelics? We explore the current limited legal pathways and potential opportunities via proposed legislation and ballot initiatives in this article.

Financing New Ventures: 10 Key Considerations to Structure an Equity Raise for a New Company

By Charlie Alovisetti, Navid Brewster
May 10, 2022

Raising money for a company is challenging. It can be even more challenging if you haven’t been through the process before and don’t know what decisions you need to make. This article lays out 10 key considerations to think about when setting up your financing.

Find VS at MJ Unpacked Cannabis Conference in New York City

May 10, 2022

We look forward to seeing our colleagues, clients, and friends in person May 18-20, 2022 at MJ Unpacked in New York City!

Charlie Alovisetti to Participate in Business of Cannabis Event: New York Sessions 'Connecting Social Equity Applicants to Capital'

Mar 1, 2022

The Business of Cannabis: New York Sessions event will focus on the critically important topic of connecting social equity licensees to capital.

[Webinar] Psychedelics Policy in Colorado & Beyond

Jan 19, 2022

Watch this live session on Thursday, January 27 at 12 p.m. MT to explore the latest in local and national psychedelics policy, with a focus on initiatives in Colorado and Denver.

[Webinar] Tri-State Cannabis Implementation Update

Jan 11, 2022

Watch this session for a look back at 2021 tri-state cannabis developments and a look forward to expectations for 2022.

Vicente Sederberg LLP Entheogens Update: December 2021

Dec 13, 2021

Update on psychedelics-related legislation and rulemaking, regulatory changes, and other noteworthy psychedelics news and events.

Financing Adaptogenic Mushroom Companies: Seven Basic Regulatory Points to Understand

By Charles Alovisetti, Joshua Kappel, Andrea Golan
Dec 2, 2021

As we wait for federal legalization and/or state-regulated psilocybin markets to emerge, what can a motivated entrepreneur interested in mycelium pursue?

[Webinar] Spotlight on Colorado's Cannabis Market

Oct 19, 2021

Watch this recorded session for an update on recent changes in the Colorado market from members of our Colorado regulatory, corporate, and hemp teams and special guest Christopher Stefan of Cannabis Capital Advisors.

What is the Process for Federal Psilocybin Registration?

By Shane Pennington
Oct 18, 2021

An introduction to the different registrations available for schedule I substances such as psilocybin and psilocin.

Charles Alovisetti and Amanda Kilroe Interviewed for Columbia Law Alumni Cannabis Article

Oct 11, 2021

The spread of legalization means a growing practice area for law firms. Two VS Columbia Law alumni were interviewed in this article.

Psychedelics and Mental Health Therapy in Colorado: DORA and Potential Regulatory Response

By James Nechleba
Oct 6, 2021

How can mental health practitioners map the new territory of psychedelics use in mental health therapy and stay within Colorado law?

VS is Headed to Las Vegas for the Biggest Cannabis Event of the Year — MJBizCon!

Oct 5, 2021

We look forward to seeing our colleagues, clients, and friends at MJBizCon in Las Vegas, October 19-22!

Barine Majewska Presents 'The Red Flags and Grey Areas in Psychedelic Practice' for CLE Companion

Sep 22, 2021

Barine Majewska presented an entheogen-focused CLE, The Red Flags and Grey Areas in Psychedelic Practice, which illuminates the top 10 issues that attorneys should consider when counseling clients in the psychedelic space.

What’s Next for Drug Policy Reform and Psychedelics in Colorado?

By Jonathan Cherkoss
Aug 30, 2021

Oregon voters passed two of the nation’s most sweeping drug policy reform measures in U.S. history in 2020, energizing grassroots organizers in Colorado and across the country. What's next for decriminalization and psychedelics reform in Colorado?

SXSW 2022 Panelpicker is Open! Vote for 'Psychedelics Ecosystem: Collaboration & Community'

Aug 13, 2021

Vote for the VS-led panel "Psychedelics Ecosystem: Collaboration & Community" to be included in SXSW 2022!

A Call for Inclusivity and Humility in the Psychedelic Renaissance

By Barine Majewska
Aug 4, 2021

When we discuss inclusivity in the quickly emerging psychedelic industry, it is important to also acknowledge the inclusivity of different viewpoints about the administration of psychedelic medicine.

Barine Majewska to Participate in Psychedelic Club of Denver's 'Exploring Ways to End the Drug War' Forum

Jul 28, 2021

VS entheogens and emerging therapies attorney Barine Majewska, alongside other leaders in the psychedelic and drug policy space will explore political and policy avenues for ending the war on drugs in this upcoming forum.

Charles Alovisetti Discusses Cannabis Policy and Cannabis Business Book with Jimmy Young on In the Weeds Podcast

Jul 2, 2021

VS partner Charles Alovisetti discussed cannabis policy and his book, The Cannabis Business, in this episode of In the Weeds with Jimmy Young podcast.

Charles Alovisetti to Present Cannabis Real Estate Financing CLE

Jul 1, 2021

The CLE, titled "Financing Cannabis-Related Real Estate: Structuring Options, Enforcement Issues, Regulatory Hurdles" will analyze legal and practical issues borrowers and lenders need to consider when documenting and funding a loan transaction secured by cannabis-related real estate.

Vicente Sederberg Once Again Ranked Top Cannabis Law Firm by Chambers and Partners

Jun 8, 2021

The prestigious international legal directory awarded VS with the 2021 'Cannabis Law - Law Firm of the Year' award, once again extended VS a Band 1 ranking, and recognized two more VS attorneys as top cannabis lawyers.

What is a Cannabis REIT?

By Charles Alovisetti, Cassia Furman
Apr 23, 2021

To many in the cannabis industry, REIT is not a common acronym. Yet, as cannabis businesses seek ways to raise funds, REITs are coming up in more and more conversations.

[Webinar] Cannabis Legalization in New York: Implementation and Opportunities

Apr 9, 2021

Watch this presentation for a look into the new law, how it will be implemented, and the opportunities it will create for businesses and individuals.

Weed Wonks Episode 56: The Nitty Gritty of Cannabis Finance with Charles Alovisetti

Apr 7, 2021

Jordan Wellington and Andrew Livingston discuss legal marijuana finance, equity, and investment with VS's Corporate Department Chair, Charles Alovisetti.

Charles Alovisetti Featured on NCIA's 'The Cannabis Industry Voice' Podcast

Apr 5, 2021

VS partner Charles Alovisetti recently talked about his book 'The Cannabis Business' with host Bethany Moore on NCIA's cannabis industry podcast

8 Key Considerations When Expanding into New Cannabis Markets

By Charles Alovisetti, Jennifer Cabrera
Mar 25, 2021

Using New Jersey as an example, here are eight important considerations companies should make when expanding into new cannabis markets.

Six Cannabis Regulatory Considerations Regarding State Receiverships

By Charles Alovisetti
Mar 19, 2021

VS partner Charles Alovisetti outlines six regulatory considerations cannabis investors and operators should keep in mind when thinking about court-supervised transfers of control of a cannabis business in this article published by Marijuana Venture.

What is a Cannabis SPAC?

By Charles Alovisetti and Ilya Ross
Feb 19, 2021

With wary investors and a minimal number of FDIC-insured bank lenders in the space, cannabis entrepreneurs are running out of options to raise capital. SPACs create a unique opportunity to fill the current vacuum of capital in the cannabis industry.

Seven Regulatory-related Factors for Marijuana Companies to Consider in a Debt Transaction

By Charles Alovisetti
Jan 25, 2021

Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.

The Cannabis Business: Introduction to Cannabis and Banking

By Charles Alovisetti and Sahar Ayinehsazian
Jan 25, 2021

As cannabis businesses become more mainstream, banks are shedding their fears about the risks of lending to this growing industry.

When Do You Need Cannabis Regulatory Counsel? A Guide for Corporate Counsel

By Charles Alovisetti, Sally Kent Peebles
Jan 15, 2021

As more law firms are fielding client questions about cannabis industry transactions, it can be challenging for corporate counsel to identify when they need cannabis regulatory counsel.

Coronavirus and Cannabis: Colorado Regulatory Updates

By Charles Alovisetti, Corey Cox, Justin Johnson, Andrew Livingston, Jessica Scardina, Jordan Wellington, Catie Wightman
Jan 11, 2021

Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on cannabis businesses, service providers, and consumers in Colorado.

The Cannabis Business: Understanding Law, Finance, and Governance in America's Newest Industry

By Vicente Sederberg LLP
Dec 18, 2020

Vicente Sederberg attorneys wrote the book on cannabis law — and now you can own it! This comprehensive primer on all things cannabis law is a must-have for anyone seeking to understand the major practical legal issues facing the marijuana and hemp industries.

Celebrating 10 Years at the Leading Edge of Cannabis Law

By Vicente Sederberg LLP
Dec 1, 2020

For our 10th anniversary, we take a look back at VS's history of leadership in cannabis law, the marijuana and hemp industries, and drug policy reform.

[Webinar] Post-election Opportunities in the Cannabis Industry

Nov 19, 2020

Watch this session for an informed look at the opportunities and other realities of operating in the cannabis industry post-election.

Cannabis in the 2020 Election: Where Did We Win?

Nov 11, 2020

Josh Kappel and Charlie Alovisetti give a post-election update for investors in this CanopyBoulder Investor Hub event.

The Impact of COVID-19 on the Cannabis Industry

By Charles Alovisetti, Sahar Ayinehsazian, Andrea Golan
Nov 5, 2020

The coronavirus and efforts to contain it have led to changes in the regulatory landscape and consumer behavior that are likely to shape the cannabis industry moving forward. In spite of COVID-19, or perhaps because of it, the cannabis industry is thriving, and will continue to do so as long as demand remains strong and operators adhere to the rules and regulations designed to keep consumers and employees safe.

2020 Elections and Cannabis: A Look at Montana's Initiatives

By Charles Alovisetti, Tucker Wentz
Oct 30, 2020

Montana is voting on two related adult-use ballot initiatives in the general election, one constitutional and one statutory

2020 Elections and Cannabis: Spotlight on South Dakota’s Measure 26 and Amendment A

By Charles Alovisetti and Kimura Mercer
Oct 30, 2020

South Dakota has two cannabis ballot measures this fall: one legalizing medical marijuana and one legalizing adult-use marijuana.

Ten Events That Shaped the Massachusetts Cannabis Industry

By Charles Alovisetti, Michelle Bodian, Elliot Choi
Oct 19, 2020

A brief history of cannabis regulation (including hemp) in the Commonwealth.

Raising Private Capital in the Cannabis Industry

By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020

Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.

[Webinar] Cannabis Mergers & Acquisitions

Aug 28, 2020

Watch this session to understand the latest trends, regulatory approval process, and common diligence issues in cannabis-related M&A transactions.

[Webinar] How Can Cannabis Businesses Maximize Tax Savings During Times of Uncertainty?

Aug 13, 2020

This session explores the complexity of mergers and acquisitions and how to optimize taxes to free cash flow for your cannabis business.

[Webinar] Private Financings in Cannabis

Aug 11, 2020

Watch this session with VS's corporate team to help maximize the chances of private capital raising success for your cannabis business or start-up.

Guide to Closing Cannabis Transactions Between Private Companies

By Charles Alovisetti, Elliot Choi, Ben Leonard, Jeremy Shaw
Aug 6, 2020

Conducting a closing is one of the more stressful tasks for junior and even senior attorneys. When a deal is ready to close, most of the principals and businesspeople are finished with their work, but lawyers are not out of the woods yet.

Using NVCA Model Documents in Cannabis Industry Financings

By Charles Alovisetti
Jul 29, 2020

The National Venture Capital Association (NVCA) provides free model documents for venture capital financings, but are they useful in the cannabis industry?

Avoiding Massive Delaware Franchise Tax Bills

By Charles Alovisetti
Jun 24, 2020

Forming a Delaware corporation is a good idea for some cannabis startups, but often results in a hefty Delaware franchise tax bill. In this article, we explain why you might actually owe less.

Preparing for the Rising Demand for Due Diligence in Cannabis Transactions

By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian, Corey Cox
May 5, 2020

The continuing growth of the cannabis and hemp industries has given rise to the need for specifically tailored due diligence.

[Webinar] Cannabis Business Taxes: How to Minimize 280E and Take Advantage of Incentives

Apr 30, 2020

It's no surprise that cannabis companies face inequitable treatment when it comes to taxes. But did you know there are ways to minimize their impact?

Vicente Sederberg Ranked Top Cannabis Law Firm by Chambers and Partners

Apr 23, 2020

The prestigious international legal directory once again gave VS a Nationwide Band 1 ranking, and this time around it also individually ranked three of the firm's partners.

Exploring Alternatives to Bankruptcy for Cannabis Businesses

By Charles Alovisetti, Phil Silverman, Jason Adelstone
Apr 17, 2020

Bankruptcy law provides advantages for financially distressed companies to restructure debt while continuing to operate. Without access to U.S. Bankruptcy Code protections, marijuana companies must turn to out-of-court restructurings and state law insolvency proceedings.

How to Get a Medical Marijuana Card via Telemedicine

By Charles Alovisetti, Brandon Kurtzman
Apr 16, 2020

Since COVID-19 has limited patient ability to get in-person consultations and examinations with health care providers, how does one go about obtaining a medical marijuana patient certification?

[Webinar] Coronavirus and Cannabis: SBA Loans and Lending for Hemp and CBD Businesses

Apr 7, 2020

Watch the replay of this discussion on federal financial assistance and lending available for hemp and CBD businesses in light of the coronavirus pandemic.

[Webinar] Coronavirus and Cannabis: Coast-to-Coast Regulatory Update

Mar 27, 2020

Watch the replay of this timely discussion on coronavirus (COVID-19) regulatory updates affecting the cannabis industry.

[Webinar] How to Take Your Michigan Cannabis Business to the Next Level

Mar 9, 2020

You received your Michigan cannabis license. Now what? Join VS and Cannabis Legal Group on March 25 to learn about how to take your business to the next level with private financing.

CU Law Cannabis Entrepreneurship Sessions

Mar 4, 2020

Colorado Law Executive Education and CU Leeds School of Business are offering a free webinar on April 21 and a "Cannabis Entrepreneurship Short Course" on June 15, 2020.

See You in Boston for CannaVest and NCIA's Northeast Cannabis Business Conference!

Feb 13, 2020

Don't miss the sessions featuring Brian Vicente, Charles Alovisetti, Ilya Ross, Jennifer Cabrera, Casey Leaver and Meg Nash. Also, be sure to meet up with VS during the event and at our pre-conference networking party!

VS Attorneys Discuss the Cannabis Industry with Business of Cannabis

Jan 22, 2020

VS attorneys Charles Alovisetti and Sahar Ayinehsazian sat down in Business of Cannabis's Canada's Scene Booth at MJBizCon 2019 to discuss the state of the cannabis industry.

Moving Forward with the MORE Act: A Look into Current Cannabis Legislation

By Charles Alovisetti, Partner
Nov 18, 2019

With a historic cannabis legislation vote approaching, let’s take a look at the current status of federal law regarding cannabis, other pieces of cannabis-related legislation that have been introduced, and what the MORE Act contains.

Public Companies Can Now Own Cannabis Licenses in Colorado

By Charles Alovisetti, Jessica Scardina, Ben Leonard, Carl Werner, and Justin Johnson
Nov 18, 2019

HB-1090 is live and Colorado's cannabis industry is officially open to publicly-traded companies and out-of-state investors. Find out what we've learned so far about this brand-new system.

Hemp M&A Transactions: Diving into the Transferability of USDA-Issued Licenses

By Elliot Choi, Counsel; Michelle Bodian, Senior Associate Attorney; Charles Alovisetti, Partner
Nov 15, 2019

Will USDA-issued hemp cultivation licenses be transferrable? Let's dive into the USDA interim final rule to find out.

Budding Companies Part 4: Jurisdiction Choice in Forming Cannabis Startups

By Charles S. Alovisetti, Partner and Caitlin Wightman, Law Clerk
Nov 8, 2019

The fourth post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post, we focus on jurisdiction choice.

Blue Sky Laws and the Cannabis Industry

By Charles S. Alovisetti, Partner
Oct 7, 2019

In addition to federal securities laws, each state and territory has its own securities laws, often referred to as blue sky laws. Cannabis company compliance with these rules may be more important due to heightened regulatory scrutiny.

Can Hemp Companies Declare Bankruptcy?

By Charles S. Alovisetti, Partner; Phil Silverman, Counsel; Jason Adelstone, Law Clerk
Sep 27, 2019

One of the many issues arising out of the tension between state and federal law in the cannabis industry is whether cannabis companies can access the protections of federal bankruptcy law.

INCBA Cannabis Law Institute 2019 Will Feature Seven Vicente Sederberg Attorneys

Sep 20, 2019

The event at New York Law School will feature many of the nation’s leading academics, politicians, and attorneys, including seven attorneys from VS.

How to Sell Hemp Food Products Without Breaking the Law

By Charles S. Alovisetti, Partner
Sep 19, 2019

Despite news headlines saying that hemp is federally legal, many hemp-derived food products and supplements currently sold in the US are in violation of federal law. But some hemp food products can actually be sold in complete compliance with US Federal law. How so?

Charles Alovisetti and Elliot Choi to Present "Due Diligence in Cannabis Industry Transactions" CLE

Sep 11, 2019

Vicente Sederberg attorneys will present a one-hour web-based CLE, "Due Diligence in Cannabis Industry Transactions," for Practising Law Institute on October 3, 2019.

Budding Companies Part 3: Governance, Exits and Investors

By Charles S. Alovisetti, Partner
Sep 9, 2019

The third post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post, we will focus on governance, exits, and investors.

Budding Companies Part 2: Audits, Investments and Other Administrative Headaches

By Charles S. Alovisetti, Partner
Sep 6, 2019

The second post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post, we will focus on taxation, audits, investments and other administrative headaches.

Budding Companies: Forming Cannabis Startups

By Charles S. Alovisetti, Partner
Sep 6, 2019

The first post in our “Budding Companies: Forming Cannabis Startups” series, where we explore different issues involved in the formation of new marijuana and hemp companies. In this post we will focus on entity choice and taxation.

Recent Status of Colorado HB19-1090: Publicly Licensed Marijuana Companies

By Charles S. Alovisetti, Partner; Jessica Scardina, Senior Associate Attorney; and Ben Leonard, Associate Attorney
Aug 26, 2019

New guidance from the Colorado MED clarifies that companies and investors can begin taking advantage of HB 1090’s more flexible regulatory structure immediately.

Understanding New Jersey’s Medical Cannabis Expansion Law

By Charles Alovisetti, Partner; Jennifer Cabrera, Counsel; and Sahar Ayinehsazian, Associate Attorney
Aug 2, 2019

Here's a look into New Jersey Assembly Bill 20, which, once implemented, will greatly expand patients’ access to medical cannabis.

Status of Colorado HB19-1090: Publicly Licensed Marijuana Companies Bill

By Charles S. Alovisetti, Partner and Sahar Ayinehsazian, Associate Attorney
Jul 16, 2019

An update on Colorado HB19-1090 "Measures to Allow Greater Investment Flexibility" and takeaways from the first legislation implementation working group.